| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KH-CB19 | CTRPv2 | pan-cancer | AAC | 0.026 | 0.6 |
| mRNA | BRD-K27224038 | CTRPv2 | pan-cancer | AAC | -0.044 | 0.6 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | BRD-K30019337 | CTRPv2 | pan-cancer | AAC | 0.042 | 0.6 |
| mRNA | NSC 74859 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.6 |
| mRNA | Ko-143 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | BRD-K80183349 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | apicidin | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |